Vox pharmaceutica - Company finances
- The company has not submitted financial data for these years: 2021.
|
EUR
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 987,541 | 209,943 | 22,240 | 9,645 |
| Profit before tax | 58,362 | 2,936 | -1,981 | 825 |
| Net profit | 55,736 | 2,496 | -1,981 | 693 |
| Equity | -77,674 | -75,178 | -77,159 | -76,466 |
| Liabilities | 0 | 342,635 | 0 | 305,174 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 251,778 | 267,457 | 229,094 | 228,708 |
| Total assets | 251,778 | 267,457 | 229,094 | 228,708 |
|
Taxes paid
|
||||
| STI taxes | - | 742 | 3,312 | 98 |
|
Financial indicators
|
||||
| Revenue change y/y | - | -78.7% | -89.4% | -56.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.1% | 0.9% | -0.9% | 0.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.6% | 1.2% | -8.9% | 7.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.9% | 1.4% | -8.9% | 8.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 329,180 | 69,981 | 7,413 | 3,215 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vox pharmaceutica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-01-16 | 2024-01-17 | 450.50 |
Vox pharmaceutica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vox pharmaceutica, UAB (code 303125909) is a Private Limited Liability Company operating in wholesale of other food. In 2025, the company generated €9.6K in revenue and €693 in net profit, resulting in a 7.2% profit margin. Revenue declined by 56.6% year on year and by 95.4% compared with 2023, when turnover reached €209.9K and net profit was €2.5K. The middle year, 2024, shows a weaker result, with revenue of €22.2K and a net loss of €2.0K, indicating a sharp contraction in activity followed by a return to profit in 2025. At the end of 2025, total assets stood at €228.7K, equity was negative at €76.5K, and liabilities amounted to €305.2K. Asset turnover was 0.04x, while return on assets was 0.3%. Revenue per employee was €3.2K and profit per employee was €231, pointing to a very small operating scale.